MMV 22nd call for proposals -2025

MMV welcomes proposals in the following areas:

1. Compounds having activity against all Plasmodium spp. blood stages in vitro  (TCP1-TPP1) for use in treatment or chemoprevention (TCP1-TPP2).
2. Compounds addressing the key priorities of the malaria elimination/ eradication agenda (TCP3).
3. Innovative biology: large molecules, biologics or oligonucleotides as long-acting injectables addressing chemoprevention.

Funding: no fixed limit 

Duration: 1 year

Research Authority due date: 20.2.25

LOI (required) due date: 28.2.25

Full proposal due date: upon request